Nuzenio

Saso Cemerski

Saso Cemerski news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Marengo Tx appoints Saso Cemerski as head of immunology - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 20:50:10 GMTSaso Cemerski: Advancing T-Cell Engager Innovation at Marengo Therapeutics - OncodailyOncodaily · Thu, 06 Aug 2026 17:21:17 GMTMarengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion - PR NewswirePR Newswire · Tue, 04 Aug 2026 11:00:00 GMTLegend Biotech names interim CEO after Ying Huang steps down - The Pharma LetterThe Pharma Letter · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 20:50:10 GMTMarengo Tx appoints Saso Cemerski as head of immunology - The Pharma Letter
Thu, 06 Aug 2026 17:21:17 GMTSaso Cemerski: Advancing T-Cell Engager Innovation at Marengo Therapeutics - Oncodaily
Tue, 04 Aug 2026 11:00:00 GMTMarengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion - PR Newswire
Tue, 28 Jul 2026 07:00:00 GMTLegend Biotech names interim CEO after Ying Huang steps down - The Pharma Letter

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Saso Cemerski.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.